Wuxi Lead Intelligent Equipment Announces Remuneration and Appraisal Committee Terms of Reference

Bulletin Express
02/10

Wuxi Lead Intelligent Equipment Co., Ltd. released details regarding its newly established Remuneration and Appraisal Committee of the Board of Directors. According to the announcement, this specialized committee is tasked primarily with formulating and reviewing remuneration policies for directors and senior management, as well as setting and evaluating their performance standards.

The committee comprises three directors and is chaired by an independent director. It is authorized to make recommendations to the Board on the structure of remuneration packages, oversee compensation arrangements for any potential loss or termination of office, and ensure such arrangements remain fair and consistent with contractual terms. The remuneration plans for directors require Board consent and further approval at shareholders’ meetings, while remuneration plans for senior management must be approved by the Board.

A working group supports the committee by providing operational and personnel data, thus aiding decision-making. In addition, directors and senior management may be requested to attend meetings if deemed necessary, but those under review must abstain from the related discussion. The announcement specifies that the meeting procedures, voting requirements, and confidentiality obligations are strictly governed by its terms of reference and are in line with current laws, regulatory provisions, and the company’s Articles of Association.

The Remuneration and Appraisal Committee’s terms of reference took effect once Wuxi Lead Intelligent Equipment’s H shares commenced listing on The Hong Kong Stock Exchange. The announcement emphasizes that any matters not covered will follow applicable laws, company regulations, and other relevant requirements of the market where its shares are listed.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10